48+ PNLE Communicable Diseases: Transmission and Prevention Review Questions Study Guide

Introduction

I used to think communicable disease transmission was “common sense.” Then the PNLE humbled me with one word, incubation, and suddenly my “common sense” was picking the wrong isolation, the wrong window period, and the wrong health teaching.

In NP3, this topic shows up as short clinical scenarios and very specific fact checks, like “What’s the incubation period?” “When is the patient most infectious?” and “Which route is NOT a mode of transmission?” They love diseases you’ve heard of (TB, Hep B, STIs) and outbreaks you’ve read about (SARS, anthrax), but they test the practical angle: stop transmission, protect contacts, educate the community.

What trips people up is mixing up incubation vs. infectious period, confusing droplet vs. airborne, and assuming bloodborne diseases spread by casual contact. Lock these patterns in, and you’ll answer faster with less second-guessing.

Key concepts

What to expect on the PNLE

Expect around 3 to 7 questions touching transmission and prevention across NP3, sometimes more if the set leans heavy on communicable disease reporting and outbreak control. The dominant style is short clinical scenarios plus recall checks on incubation periods, mode of transmission, and “which is NOT” items.

• Scenarios that keep showing up: respiratory outbreak (SARS-like) asking primary mode and when they’re most infectious, Hepatitis B risk and non-transmission routes, and STI cases asking incubation or the best prevention method.
• Most common pattern that burns points: negative stems. If you miss the NOT, you will confidently choose the exact opposite of the right answer.
• Trap answer type: something technically true but not the priority, like “give health teaching” when the immediate correct answer is hand hygiene, correct PPE, or isolating the source to stop spread now.
• What PNLE really rewards: practical public health reasoning. Identify route, cut the route, protect contacts, and pick the most effective, realistic prevention action.

If you can do those steps fast, this topic turns into free points.

Study tips

• Make a “route to precaution” mini-table: On the left write Contact, Droplet, Airborne, Bloodborne, Food/Water, Vector. On the right list the first nursing action (PPE or community control), for example droplet equals surgical mask and distance, airborne equals N95 and ventilation, bloodborne equals sharps safety and condom teaching.
• Separate “Incubation” and “Most infectious” in your notes: Use two columns per disease. For respiratory outbreaks like SARS, add one line: “Peak infectivity tends to be around symptomatic phase,” so you stop guessing based on incubation alone.
• Memorize high-yield STI incubation with a tight set: Focus on the ones PNLE keeps recycling, gonorrhea, trichomoniasis, and syphilis stages. Write them on one index card and test yourself twice a day for 3 minutes.
• Use “NOT transmitted by” drills: For Hepatitis B, practice eliminating wrong routes: casual contact, sharing utensils, hugging, coughing. This is low effort and high points because PNLE loves negative phrasing.
• Teach it out loud in 5 minutes: Explain the chain of infection to a classmate, or to a wall if everyone’s busy. If you can say “portal of exit is sputum, transmission is droplet, so my control is mask and cough etiquette,” you’ll crush scenario items.
• Do targeted sets on tangerine.: You have 48 questions available, mostly easy and medium. Do them in batches of 10, then tag every miss as either “route,” “incubation,” or “isolation,” so your next set is attacking the real weakness.

Common mistakes to avoid

• Mixing up incubation with infectious period: You read the question, you see “SARS” and your brain goes “incubation is long, so they’re infectious for weeks before symptoms,” and you pick a contact-tracing window that’s too wide. But the PNLE wants you to separate timelines, incubation is exposure to symptoms, peak infectivity is tied to when viral shedding is highest, often around symptomatic phases. This one catches a lot of people because both timelines sound like “how long the disease lasts.”
• Calling a bloodborne disease ‘casually contagious’: You see Hepatitis B and you pick “sharing eating utensils” or “kissing” as a transmission route because saliva exists. But the PNLE wants blood and certain body fluids through sex, needles, and perinatal routes, with prevention like vaccination, safe sex, and sharps safety. This one catches a lot of people because it feels safer to assume everything spreads easily.
• Overusing airborne precautions: You read “respiratory symptoms,” your gut says “airborne, N95 for everyone,” because you don’t want to be wrong. But the PNLE often wants droplet as primary for many respiratory infections and outbreak templates, plus source control like masking the patient and cough etiquette. This one catches a lot of people because “airborne” sounds like the highest level answer.
• Missing the word NOT: You read fast, you see “mode of transmission,” and you pick the most familiar route, but the stem asked “Which is NOT transmitted by…?” PNLE writers love this because it punishes autopilot, especially with Hep B and anthrax. The fix is boring but effective, circle NOT in your head before you look at choices.
• Choosing treatment when the question is prevention: You see an STI scenario and you jump to “give antibiotics now” because that’s what you’d do in clinic. But NP3 questions often ask the community prevention priority, like condoms, partner notification, and education on completing treatment to stop reinfection. This one catches a lot of people who are strong in medical-surgical but forget the public health angle.

Practice questions

References and further reading

• Severe Acute Respiratory Syndrome (SARS) government
  WHO’s SARS overview includes key exam-relevant points on incubation period (typically 2–7 days, up to 10) and transmission (including indirect transmission via contaminated surfaces), useful for community health prevention concepts.
• SARS | Core Guidance | Clinical, Epi, and Virologic Features of SARS-CoV government
  CDC’s archived SARS guidance summarizes incubation period (median ~4–6 days; most ill within 2–10 days) and clinical/epidemiologic features for classic SARS, aligning with common licensure-style questions.
• COVID-19 | Yellow Book | CDC government
  CDC’s Yellow Book chapter provides a clear, practical summary of respiratory transmission (airborne particles and droplets) and infectivity timing (including infectiousness 1–2 days before symptoms and early peak transmission), applicable to community prevention counseling.
• Hepatitis B (Fact sheet) government
  WHO’s Hepatitis B fact sheet covers transmission routes, incubation period range (30–180 days), and the high likelihood of chronic infection when infected in infancy/early childhood—key for PNLE risk-group and prevention questions.
• Hepatitis B Prevention and Control | Hepatitis B | CDC government
  CDC prevention guidance explicitly lists non-transmission routes (e.g., not spread through hugging, coughing/sneezing, breastfeeding, or food/water; not spread through kissing or sharing utensils) and prevention measures important for patient education items.
• Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings guideline
  CDC’s Isolation Precautions guideline is a cornerstone reference for Standard and Transmission-Based Precautions (contact/droplet/airborne), supporting nursing interventions that prevent communicable disease spread in community and facility settings.
• WHO guidelines on hand hygiene in health care guideline
  This WHO guideline is a primary evidence-based reference for hand hygiene recommendations and implementation strategies—foundational for preventing transmission of communicable diseases.
• Preventing hepatitis in health care settings government
  WHO guidance emphasizes universal precautions, safe sharps/injection practices, waste disposal, and hepatitis B vaccination for health care workers—core prevention themes for communicable diseases in community and clinical contexts.